Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Geriatric MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2016. Available at: http://goldcopd.org. Accessed November 1, 2016.
- Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010.Respir Res. 2013; 14: 103
Centers for Disease Control and Prevention NCHS, 1998-2009. Available at: http://www.cdc.gov/nchs/data/databriefs/db63_tables.pdf#2. Accessed November 18, 2016.
- Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study.Lancet. 2005; 366: 1875-1881
- International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study.Lancet. 2007; 370: 741-750
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the global burden of disease study 2010.Lancet. 2012; 380: 2163-2196
- Global burden of COPD.Respirology. 2016; 21: 14-23
- Chronic obstructive pulmonary disease in non-smokers.Lancet. 2009; 374: 733-743
- Projections of global mortality and burden of disease from 2002 to 2030.PLoS Med. 2006; 3: e442
- Diagnostic labeling of COPD in five Latin American cities.Chest. 2007; 131: 60-67
- Determinants of underdiagnosis of COPD in national and international surveys.Chest. 2015; 148: 971-985
- Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure.Respir Care. 2006; 51: 1120-1124
- COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity.Chest. 2002; 121: 121S-126S
- Measuring the global burden of disease.N Engl J Med. 2013; 369: 448-457
- 2nd edition. The lung: scientific foundations. vol. 2. Lippincott-Raven, Philadelphia1997: 2193-2203
- Understanding the odd science of aging.Cell. 2005; 120: 437-447
- Free radical theory of aging: an update: increasing the functional life span.Ann N Y Acad Sci. 2006; 1067: 10-21
- Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2012; 186: 155-161
- Accelerated ageing of the lung in COPD: new concepts.Thorax. 2015; 70: 482-489
- Various mechanistic pathways representing the aging process are altered in COPD.Chest. 2016; 149: 53-61
- Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2007; 175: 1259-1265
- Airway obstruction in never smokers: results from the third national health and nutrition examination survey.Am J Med. 2005; 118: 1364-1372
- Respiratory symptoms, spirometric respiratory impairment, and respiratory disease in middle-aged and older persons.J Am Geriatr Soc. 2015; 63: 251-257
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.Eur Respir J. 2004; 23: 932-946
- Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.Ann Intern Med. 2011; 155: 179-191
- Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%.Chest. 2007; 131: 349-355
- The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2010; 181: 446-451
- Reference ranges for spirometry across all ages: a new approach.Am J Respir Crit Care Med. 2008; 177: 253-260
- Airflow limitation by the global lungs initiative equations in a cohort of very old adults.Eur Respir J. 2015; 46: 123-132
- Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2005; 171: 591-597
- Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease.Ann Am Thorac Soc. 2014; 11: 1351-1361
- An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease.Eur Respir J. 2014; 44: 1428-1446
- The 6-min walk distance: change over time and value as a predictor of survival in severe COPD.Eur Respir J. 2004; 23: 28-33
- Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization.Am J Respir Crit Care Med. 2013; 187: 382-386
- The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med. 2004; 350: 1005-1012
- Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Chest. 2013; 143: e78S-e92
- Lung cancer screening in patients with chronic obstructive pulmonary disease.Ann Transl Med. 2016; 4: 160
- Toward a consensus definition for COPD exacerbations.Chest. 2000; 117: 398S-401S
- Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2005; 172: 1510-1516
- Physiological changes during symptom recovery from moderate exacerbations of COPD.Eur Respir J. 2005; 26: 420-428
- Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD.Chest. 2007; 131: 37-43
- Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity.J Appl Physiol (1985). 2009; 106: 1902-1908
- Pulmonary arterial enlargement and acute exacerbations of COPD.N Engl J Med. 2012; 367: 913-921
- Impact of COPD exacerbations on patient-centered outcomes.Chest. 2007; 131: 696-704
- Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.Thorax. 2005; 60: 925-931
- Smoking cessation for people with chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2016; (CD010744)
- Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study.Chest. 2004; 125: 2011-2020
- The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.N Engl J Med. 1994; 331: 778-784
- Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2010; (CD001390)
- Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease.Clin Infect Dis. 2012; 55: e35-e44
- Medication adherence issues in patients treated for COPD.Int J Chron Obstruct Pulmon Dis. 2008; 3: 371-384
- Can all patients with COPD use the correct inhalation flow with all inhalers and does training help?.Respir Med. 2007; 101: 2395-2401
- Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease.Am J Health Syst Pharm. 2011; 68: 1221-1232
- Chronic obstructive pulmonary disease: prevalence, characteristics, and pharmacologic treatment in nursing home residents with cognitive impairment.J Manag Care Pharm. 2012; 18: 598-606
- Dry powder inhalers: an overview.Respir Care. 2005; 50 ([discussion: 1312]): 1304-1312
- Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD.Respir Med. 2008; 102: 593-604
- Aerosol drug delivery: developments in device design and clinical use.Lancet. 2011; 377: 1032-1045
- Considerations for managing chronic obstructive pulmonary disease in the elderly.Clin Interv Aging. 2014; 9: 23-30
- Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.Lancet. 2015; 385: 857-866
- Azithromycin for prevention of exacerbations of COPD.N Engl J Med. 2011; 365: 689-698
- An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.Am J Respir Crit Care Med. 2013; 188: e13-e64
- Pulmonary rehabilitation and outcome measures in elderly patients with chronic obstructive pulmonary disease.Gerontology. 2001; 47: 241-245
- Endurance and strength training in patients with COPD.Chest. 2004; 125: 2036-2045
- Exercise training and nutritional supplementation for physical frailty in very elderly people.N Engl J Med. 1994; 330: 1769-1775
- Effect of coexisting chronic obstructive pulmonary disease and cognitive impairment on health outcomes in older adults.J Am Geriatr Soc. 2012; 60: 1839-1846
- Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial.Am J Respir Crit Care Med. 2003; 167: 880-888
- Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial.Lancet. 2000; 355: 362-368
- Benefits of long-term pulmonary rehabilitation maintenance program in severe COPD patients: 3 year follow-up.Am J Respir Crit Care Med. 2017; 195: 622-629
- Predicting falls within the elderly community: comparison of postural sway, reaction time, the berg balance scale and the activities-specific balance confidence (ABC) scale for comparing fallers and non-fallers.Arch Gerontol Geriatr. 2004; 38: 11-26
- The timed “Up & Go”: a test of basic functional mobility for frail elderly persons.J Am Geriatr Soc. 1991; 39: 142-148
- Towards integration of palliative care in patients with chronic heart failure and chronic obstructive pulmonary disease: a systematic literature review of European guidelines and pathways.BMC Palliat Care. 2016; 15: 18
- Palliative and end-of-life care for patients with severe COPD.Eur Respir J. 2008; 32: 796-803
Article info
Publication history
Published online: August 22, 2017
Footnotes
Disclosure: V. Pinto-Plata has served as an advisory board member for Astra-Zeneca, Mylan Pharmaceutical, and GlaxoSmithKline.
Identification
Copyright
© 2017 Elsevier Inc. All rights reserved.
